https://www.drivephasepv.com/blog daily 0.75 2024-04-30 https://www.drivephasepv.com/blog/2024/4/30/compliance-with-risk-minimisation-strategies-expectations-from-regulatory-authorities monthly 0.5 2024-04-30 https://images.squarespace-cdn.com/content/v1/5a4c0b9832601efc8b398f8d/2008909c-ec77-4d58-afb2-31b54113f842/Screenshot+2024-04-30+130838.png Blog - Compliance with Risk Minimisation Strategies – Expectations from Regulatory Authorities - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.drivephasepv.com/blog/2022/10/13/2020-21-mhra-pv-inspection-metric-report monthly 0.5 2022-10-14 https://www.drivephasepv.com/blog/2021/8/5/the-role-of-ai-in-transforming-pharmacovigilance-in-clinical-trials monthly 0.5 2021-08-05 https://www.drivephasepv.com/blog/2021/6/28/first-do-no-harm monthly 0.5 2021-06-29 https://www.drivephasepv.com/blog/2019/9/26/move-for-drive-phase-pv monthly 0.5 2019-09-26 https://www.drivephasepv.com/blog/2018/11/27/patient-registries-for-pv monthly 0.5 2018-11-30 https://www.drivephasepv.com/blog/2018/9/26/4-brexit-contingency-plans-for-pharmacovigilance monthly 0.5 2019-10-17 https://www.drivephasepv.com/blog/2018/8/24/4-ways-to-optimise-clinical-development-with-pharmacovigilance monthly 0.5 2019-10-17 https://www.drivephasepv.com/blog/2018/6/22/pv-and-social-media-the-full-article monthly 0.5 2018-09-26 https://www.drivephasepv.com/blog/2018/5/31/sodium-valproate-and-safety-communication monthly 0.5 2020-07-08 https://www.drivephasepv.com/blog/2018/5/15/two-years-of-prime monthly 0.5 2018-09-26 https://www.drivephasepv.com/blog/2018/5/11/pv-and-social-media monthly 0.5 2018-09-26 https://www.drivephasepv.com/blog/2018/4/27/drive-phase-pv-launches monthly 0.5 2018-09-26 https://www.drivephasepv.com/blog/tag/GVP monthly 0.5 https://www.drivephasepv.com/blog/tag/PRAC monthly 0.5 https://www.drivephasepv.com/blog/tag/PHARMACOVIGILANCE+CONSULTANT monthly 0.5 https://www.drivephasepv.com/blog/tag/PHARMACOVIGILANCE+CONSULTANCY monthly 0.5 https://www.drivephasepv.com/blog/tag/Risk+Minimisation+Plan monthly 0.5 https://www.drivephasepv.com/blog/tag/Pharmacovigilance monthly 0.5 https://www.drivephasepv.com/blog/tag/pharmacovigilance+consultant monthly 0.5 https://www.drivephasepv.com/blog/tag/PHARMACOVIGILANCE+SERVICES monthly 0.5 https://www.drivephasepv.com/blog/tag/PHARMACOVIGILANCE monthly 0.5 https://www.drivephasepv.com/blog/tag/Pharmacovigilance+Brexit monthly 0.5 https://www.drivephasepv.com/blog/tag/Additional+Risk+Mnimisation+Activities monthly 0.5 https://www.drivephasepv.com/blog/tag/pharmacovigilance+consultancy monthly 0.5 https://www.drivephasepv.com/blog/tag/Risk+Minimisation+Activities monthly 0.5 https://www.drivephasepv.com/blog/tag/Safety+communication monthly 0.5 https://www.drivephasepv.com/blog/tag/GCP monthly 0.5 https://www.drivephasepv.com/blog/tag/Pharmacovigilance+Consultant monthly 0.5 https://www.drivephasepv.com/blog/tag/clinical+trials monthly 0.5 https://www.drivephasepv.com/blog/tag/Sodium+valproate monthly 0.5 https://www.drivephasepv.com/blog/tag/Pharmacovigilance+Services monthly 0.5 https://www.drivephasepv.com/industry-news daily 0.75 2023-07-06 https://www.drivephasepv.com/industry-news/2023/7/6/medicines-and-healthcare-products-regulatory-agency-corporate-plan-2023-to-2026 monthly 0.5 2023-07-06 https://www.drivephasepv.com/industry-news/2023/5/26/mhra-consultation-on-ich-e6-r3-good-clinical-practice-gcp-guidelines monthly 0.5 2023-05-26 https://www.drivephasepv.com/industry-news/2023/4/4/mhra-gcp-inspection-metrics monthly 0.5 2023-04-04 https://www.drivephasepv.com/industry-news/2023/2/6/pmcpa-social-media-guidance-2023 monthly 0.5 2023-02-24 https://www.drivephasepv.com/industry-news/2023/1/24/cioms-glossary-of-ich-terms-and-definitions monthly 0.5 2023-02-24 https://www.drivephasepv.com/industry-news/2022/11/2/mhra-updated-guidance-on-pharmacovigilance-procedures monthly 0.5 2023-02-24 https://www.drivephasepv.com/industry-news/2022/10/14/cioms-xi-patient-involvement-in-the-development-regulation-and-safe-use-of-medicines monthly 0.5 2023-02-24 https://www.drivephasepv.com/industry-news/tag/GVP monthly 0.5 https://www.drivephasepv.com/industry-news/tag/CLINICAL+TRIALS monthly 0.5 https://www.drivephasepv.com/industry-news/tag/PHARMACOVIGILANCE+CONSULTANCY monthly 0.5 https://www.drivephasepv.com/industry-news/tag/pharmacovigilance monthly 0.5 https://www.drivephasepv.com/industry-news/tag/PHARMACOVIGILANCE monthly 0.5 https://www.drivephasepv.com/industry-news/tag/Pharmacovigilance+audit monthly 0.5 https://www.drivephasepv.com/industry-news/tag/PHARMACOVIGILANCE+AUDIT monthly 0.5 https://www.drivephasepv.com/industry-news/tag/MHRA monthly 0.5 https://www.drivephasepv.com/industry-news/tag/pharmacovigilance+consultancy monthly 0.5 https://www.drivephasepv.com/industry-news/tag/GCP monthly 0.5 https://www.drivephasepv.com/industry-news/tag/Patient+safety monthly 0.5 https://www.drivephasepv.com/industry-news/tag/clinical+trials monthly 0.5 https://www.drivephasepv.com/industry-news/tag/Good+Clinical+Practice monthly 0.5 https://www.drivephasepv.com/home daily 1.0 2023-01-23 https://images.squarespace-cdn.com/content/v1/5a4c0b9832601efc8b398f8d/51f16ad2-f859-4d0e-a3b8-8fe6326c6eb2/unsplash-image-Q0AM87PsYkE.jpg Drive Phase PV - Background Established in 2018, Drive Phase PV Limited is a UK-based pharmacovigilance consultancy and service provider, supporting patient safety throughout the life-cycle of our clients' products. Named after the crucial first steps after the starting pistol goes, fail to set yourself up correctly in those opening moments and you are never going to achieve your potential and will be left in others wake. We work with a large range of clients, from sponsors of single centre Phase 1 studies through to Top 10 pharmaceutical companies, ensuring drug safety is maintained in clinical and post-marketing settings. https://images.squarespace-cdn.com/content/v1/5a4c0b9832601efc8b398f8d/1522076230852-RSUJMFUXB8FK0FOFPB79/shutterstock_632153213.jpg Drive Phase PV https://www.drivephasepv.com/post-marketing-services daily 0.75 2023-03-10 https://images.squarespace-cdn.com/content/v1/5a4c0b9832601efc8b398f8d/51f16ad2-f859-4d0e-a3b8-8fe6326c6eb2/unsplash-image-Q0AM87PsYkE.jpg Post-Marketing Pharmacovigilance - Areas of Expertise Drive Phase PV offers comprehensive post-marketing pharmacovigilance support. Whatever your company’s set-up, we can develop and maintain a PV system that is unique to you and maintain compliance in an ever more complicated regulatory landscape. https://images.squarespace-cdn.com/content/v1/5a4c0b9832601efc8b398f8d/1522077912250-3A0OWLR2ICDKE5L67ALX/shutterstock_632153213.jpg Post-Marketing Pharmacovigilance https://www.drivephasepv.com/about daily 0.75 2023-09-14 https://images.squarespace-cdn.com/content/v1/5a4c0b9832601efc8b398f8d/d5dcbd2c-d05d-4911-8ebc-8cdffa600407/DSCF4834-1.JPG About https://images.squarespace-cdn.com/content/v1/5a4c0b9832601efc8b398f8d/193bd120-2981-433a-9f87-135c244853a1/DSCF4831-1.JPG About - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/5a4c0b9832601efc8b398f8d/1407ff58-7956-410f-8b52-496cce564e06/DSCF4823-1.JPG About - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/5a4c0b9832601efc8b398f8d/1522077912250-3A0OWLR2ICDKE5L67ALX/shutterstock_632153213.jpg About https://www.drivephasepv.com/contact-us daily 0.75 2023-04-04 https://images.squarespace-cdn.com/content/v1/5a4c0b9832601efc8b398f8d/1522077912250-3A0OWLR2ICDKE5L67ALX/shutterstock_632153213.jpg Contact Us https://www.drivephasepv.com/clinical-safety-services daily 0.75 2023-08-25 https://images.squarespace-cdn.com/content/v1/5a4c0b9832601efc8b398f8d/51f16ad2-f859-4d0e-a3b8-8fe6326c6eb2/unsplash-image-Q0AM87PsYkE.jpg Clinical Safety - Areas of Expertise Drive Phase PV offers pharmacovigilance support at all stages of clinical development. Phase 1 may often be referred to as ‘Safety Studies’ but PV doesn’t end there and getting it right at this early stage can reap dividends further down the line in terms of speeding up time to market. Whatever your company’s development strategy, we can develop and maintain a PV system that is unique to you and your goals. https://images.squarespace-cdn.com/content/v1/5a4c0b9832601efc8b398f8d/1522077912250-3A0OWLR2ICDKE5L67ALX/shutterstock_632153213.jpg Clinical Safety https://www.drivephasepv.com/brexitreadiness daily 0.75 2022-08-12 https://images.squarespace-cdn.com/content/v1/5a4c0b9832601efc8b398f8d/51f16ad2-f859-4d0e-a3b8-8fe6326c6eb2/unsplash-image-Q0AM87PsYkE.jpg Brexit - PV in the UK The future of pharmacovigilance in the EU and UK is unclear, but Drive Phase PV can help manage your PV system through the next few years. From providing UK QPPV support to complete system reconfiguration, we will ensure compliance and patient safety during this uncertain time. https://images.squarespace-cdn.com/content/v1/5a4c0b9832601efc8b398f8d/1c5f43a9-5378-4f68-977f-1ca8935900ea/unsplash-image-8Yw6tsB8tnc.jpg Brexit - Make it stand out Drive Phase PV Blog Post: 4 Ways to Brexit-Proof your Pharmacovigilance System https://images.squarespace-cdn.com/content/v1/5a4c0b9832601efc8b398f8d/36cb0bed-abfc-457d-a7ac-ea42c28e7f35/unsplash-image-o-ubWHV29Uk.jpg Brexit - Make it stand out MHRA: Exceptions and Modifications to the EU Guidance on Good Pharmacovigilance Practices that Apply to UK MAHs and the MHRA https://images.squarespace-cdn.com/content/v1/5a4c0b9832601efc8b398f8d/1522077912250-3A0OWLR2ICDKE5L67ALX/shutterstock_632153213.jpg Brexit https://www.drivephasepv.com/athlete-sponsorship daily 0.75 2025-11-27 https://images.squarespace-cdn.com/content/v1/5a4c0b9832601efc8b398f8d/f5ed0ad7-2185-445e-b186-2c963eef36e7/IMG_4440.jpg Athletes - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/5a4c0b9832601efc8b398f8d/47d6f319-b65e-4c8e-a82e-18e9f46ee70f/ff2bcc1b-4d6b-4134-9c66-3a454fb2ddec.JPG Athletes - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/5a4c0b9832601efc8b398f8d/0457d845-caa5-4dfa-bad0-f5adf913389f/Bobsled+Pic.JPG Athletes - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/5a4c0b9832601efc8b398f8d/1522077912250-3A0OWLR2ICDKE5L67ALX/shutterstock_632153213.jpg Athletes https://www.drivephasepv.com/safety-database daily 0.75 2023-08-25 https://images.squarespace-cdn.com/content/v1/5a4c0b9832601efc8b398f8d/1679669537242-6MAC8QOS4MDD0R11MH03/Screenshot+2023-03-24+143710.png Managing Safety Data https://images.squarespace-cdn.com/content/v1/5a4c0b9832601efc8b398f8d/1679669537218-C88404CHK260V7CTUA8Q/Screenshot+2023-03-24+144815.png Managing Safety Data https://images.squarespace-cdn.com/content/v1/5a4c0b9832601efc8b398f8d/1679669538234-1HZMW4JG269MY92II4LZ/Screenshot+2023-03-24+145102.png Managing Safety Data https://images.squarespace-cdn.com/content/v1/5a4c0b9832601efc8b398f8d/1679670613104-TF8NWIQI1LHYHA0Z54B8/Screenshot+2023-03-24+150725.png Managing Safety Data https://images.squarespace-cdn.com/content/v1/5a4c0b9832601efc8b398f8d/1679670213230-FDCPKE1ZX07EHG654EQL/Screenshot+2023-03-24+145907.png Managing Safety Data https://images.squarespace-cdn.com/content/v1/5a4c0b9832601efc8b398f8d/1679668414587-UVUZTGW6Y5GUFHY9GDNM/Screenshot+2023-03-24+124547.png Managing Safety Data https://images.squarespace-cdn.com/content/v1/5a4c0b9832601efc8b398f8d/1679668414542-YU1NQ8SZG9QWNVCSX5AY/Screenshot+2023-03-24+124222.png Managing Safety Data https://images.squarespace-cdn.com/content/v1/5a4c0b9832601efc8b398f8d/1679668415445-5EPA84VEWFYI2NE4B93M/Screenshot+2023-03-24+125710.png Managing Safety Data https://images.squarespace-cdn.com/content/v1/5a4c0b9832601efc8b398f8d/1678443694229-UAVF61NGFN901Z7GZBI5/unsplash-image-kUqqaRjJuw0.jpg Managing Safety Data - AB Cube SafetyEasy® •Drive Phase PV offers safety data management solutions with AB Cube’s SafetyEasy Database - a cloud-based database software for effortless pharmacovigilance (PV) compliance, but also for medical device (MD) vigilance, cosmetovigilance and nutrivigilance •Streamlined system for processing and reporting adverse events in a fully E2B(R3) compliant manner •Quick to set up with implementation within 2 weeks, and can be uniquely configured according to the client’s needs •In 2021, SafetyEasy was selected by the Agence nationale de sécurité du médicament et des produits de santé (ANSM) as its PV safety database. https://images.squarespace-cdn.com/content/v1/5a4c0b9832601efc8b398f8d/1522077912250-3A0OWLR2ICDKE5L67ALX/shutterstock_632153213.jpg Managing Safety Data